Emergency Physician, Department of Emergency, Merkezefendi State Hospital, Manisa, Turkey.
Emergency Physician, Department of Emergency, Tepecik Training and Research Hospital, Izmir, Turkey.
Prehosp Disaster Med. 2024 Apr;39(2):178-183. doi: 10.1017/S1049023X24000141. Epub 2024 Mar 8.
Lactate is a frequently used biomarker in emergency departments (EDs), especially in critically ill patients. The aim of this study is to investigate the relationship between lactate and lactate clearance with in-hospital mortality in unselected ED patients.
This study was carried out retrospectively in the ED of a tertiary hospital. Patients aged 18 years and older whose blood lactate level was obtained in the ED were included in the study. Patients whose lactate value did not have sufficient analytical accuracy, whose lactate value was recorded in the system 180 minutes after admission, who were admitted to the ED as cardiac arrest, and whose ED or hospital outcome was unknown were excluded from the study. According to the first measured lactate value, the patients were divided into three groups: < 2.0mmol/L, 2.0-3.9mmol/L, and ≥ 4.0mmol/L. Lactate clearance was calculated and recorded in patients with one-to-four hours between two lactate values.
During the five-year study period, a total of 1,070,406 patients were admitted to the ED, of which 114,438 (10.7%) received blood gas analysis. The median age of 81,449 patients included in the study was 58 years (IQR: 30, min: 18-max: 117) and 54.4% were female. The study found that non-trauma patients with a lactate level between 2.0-3.9mmol/L had a 2.5-times higher mortality risk, while those with a lactate level of ≥ 4.0mmol/L had a 20.8-times higher risk, compared to those with a lactate level < 2.0mmol/L. For trauma patients, the mortality risk was three-times higher for those with lactate levels between 2.0-3.9mmol/L and nine-times higher for those with a lactate level of ≥ 4.0mmol/L, compared to those with a lactate level < 2.0mmol/L. Among patients with a first measured lactate value ≥ 4.0mmol/L and a two-hour lactate clearance < 20%, the mortality rate was 19.7%. In addition, lactate, lactate clearance, and age were independent variables for mortality in this patient group.
The lactate value in unselected patients in the ED is a biomarker that can be used to predict the prognosis of the patients. In addition, lactate, lactate clearance, and age are independent predictors of mortality.
乳酸是急诊科(ED)中常用的生物标志物,尤其在危重症患者中。本研究旨在探讨非选择性急诊科患者血乳酸水平及其清除率与院内死亡率之间的关系。
本研究为回顾性研究,在一家三级医院的急诊科进行。纳入标准为年龄≥18 岁且在急诊科获得血乳酸水平的患者。排除标准为血乳酸值分析不精确、入院 180 分钟后系统记录血乳酸值、以心脏骤停入院、ED 或医院结局未知的患者。根据首次测量的乳酸值,患者被分为三组:<2.0mmol/L、2.0-3.9mmol/L 和≥4.0mmol/L。在有 1-4 小时两次乳酸值的患者中计算并记录乳酸清除率。
在五年的研究期间,共有 1070406 名患者被收入 ED,其中 114438 名(10.7%)接受了血气分析。纳入研究的 81449 名患者的中位年龄为 58 岁(IQR:30,min:18-max:117),54.4%为女性。研究发现,与血乳酸水平<2.0mmol/L的非创伤患者相比,血乳酸水平在 2.0-3.9mmol/L 之间的患者死亡率高 2.5 倍,而血乳酸水平≥4.0mmol/L的患者死亡率高 20.8 倍。对于创伤患者,血乳酸水平在 2.0-3.9mmol/L 之间的患者死亡率高 3 倍,血乳酸水平≥4.0mmol/L的患者死亡率高 9 倍,而血乳酸水平<2.0mmol/L的患者死亡率低。在首次血乳酸值≥4.0mmol/L且两小时乳酸清除率<20%的患者中,死亡率为 19.7%。此外,乳酸、乳酸清除率和年龄是该患者组死亡的独立变量。
ED 中未选择的患者的乳酸值是一种可用于预测患者预后的生物标志物。此外,乳酸、乳酸清除率和年龄是死亡率的独立预测因子。